RARA CRAFT DATABASE for FDA Medical Devices
510(k)K213659

FDA DEVICE FACTS

LigaPASS™ 2.0 Ligament Augmentation System

Medicrea International SA

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 24, 2022PRODUCT CODEOWI

Indications for use

The LigaPASS ™ system is an implant for use in orthopaedic surgery. The system is intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. The indications for use are as follows:

• Spinal trauma surgery, used in sublaminar or facet wiring techniques;

• Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinal deformities such as idiopathic and neuromuscular scoliosis in patients 8 years of age and older, adults scoliosis and kyphosis;

• Spine degenerative surgery as an adjunct to spinal fusions.

• Intended for use with a posterior spinal instrumentation construct when ligament augmentation is needed. The LigaPASS ™ system may also be used in conjunction with other medical imp lants made of titanium or cobal t-chrome alloy whenever "wiring" may help secure the attachment of other impl ants.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026